… use of convalescent plasma during the present-day SARS-CoV-… required to make convalescent
plasma treatments readily … had more patients than most published convalescent plasma …

… -2) is the virus that causes coronavirus disease 2019 (COVID… trials on convalescent plasma
therapy in pediatric patients with … of children treated with convalescent plasma therapy (14 …

… Convalescent plasma is safe, does not improve survival, has … the respiratory tract, influence
SARS-CoV-2 antibody development … of patients already had potent neutralizing SARS-CoV-2 …

… viable SARS-CoV from the urine of a convalescent patient has not been reported previously.
Our isolation of living SARS-CoV from the stool specimens of convalescent SARS patients …

… In another analysis of the dynamics of neutralizing antibody titers in eight convalescent
patients with COVID-19, four patients showed decreased neutralizing antibodies approximately 6…

… Management with convalescent plasma for treating the SARS patients resulted in reduced
hospital stay and decreased mortality. Following the administration of this plasma, no acute …

Long-term antibody responses and neutralizing activities in response to SARS-CoV-2
infection are not yet clear. Here we quantify immunoglobulin M (IgM) and G (IgG) antibodies …

… parallel efforts using both humanized mice and convalescent patients to generate antibodies
against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, …

… of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was … convalescent,
double mRNA-vaccinated, mRNA-boosted, convalescent double-vaccinated and convalescent …

… optimal convalescent plasma donors. The aim of this study was to characterize SARS-CoV-2 …
and convalescent patients, and compare their association with neutralizing antibody titers. …